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Learning Objectives
===================

Upon completion of this activity, participants will be able to:

-   Describe the transmission mechanism and attack rate for the H7 strain of influenza virus in humans

-   Describe clinical manifestations of H7 virus infection in humans

-   Identify reasons for increased prevalence of human infection with the H7 virus in future

-   Describe differences in clinical presentation of infection with H5N1 and H7 viruses

-   Identify the best strategy for protection against avian virus infection for humans
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CME Questions
=============

1.  Which of the following best describes the anticipated attack rate of a pandemic influenza virus on the basis of attack rates in past pandemics?

    1.  A. 10% to 15%

    2.  B. 25% to 35%

    3.  C. 40% to 50%

    4.  D. 55% to 65%

2.  Which of the following is least likely to be an early clinical manifestation of H7 influenza virus?

    1.  A. Pneumonia

    2.  B. Conjunctivitis

    3.  C. Coryza

    4.  D. Encephalitis

3.  Which of the following is the most likely reason for expectations of future human infection with the H7 avian influenza virus?

    1.  A. Increased detection in nonpoultry farm animals

    2.  B. Increased frequency of human and poultry infection

    3.  C. Increased detection of human infection in the African continent

    4.  D. All of the above

4.  Which of the following best describes the difference between infection with H5N1 and H7 subtypes of the avian influenza virus in humans?

    1.  A. H5N1 manifests most frequently as neurologic disease

    2.  B. H7 most frequently manifests as conjunctival disease

    3.  C. H7 manifests only rarely as respiratory disease

    4.  D. The 2 infections are indistinguishable clinically

5.  Which of the following strategies is considered the best protection of humans against avian influenza viruses?

    1.  A. Antiviral agents

    2.  B. Quarantine and slaughter of infected poultry

    3.  C. Vaccination of humans

    4.  D. Handwashing hygiene measures
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